Education
About Us
Working with TipRanks
Follow Us
Joseph Oliveto Insider Profile
4 Followers
Joseph Oliveto, President and CEO, Director at Chelsea Therapeutics, holds 482.74K shares in Milestone Pharmaceuticals (Ticker: MIST), holds 0.00 shares in Chelsea Therapeutics (Ticker: CHTP).
Joseph Oliveto Chelsea Therapeutics (CHTP)President and CEO, Director
Chelsea Therapeutics (CHTP)
President and CEO, Director
Not Ranked
Joseph Oliveto has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Joseph Oliveto holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Joseph Oliveto
Joseph Oliveto's Trading History
Chelsea Therapeutics
Jun 25, 2014
―
Uninformative Sell
―
―
Milestone Pharmaceuticals
Jan 28, 2026
President & CEO, Director
Uninformative Buy
414.93K
$767.56K
List of latest transactions for each holding click on a transaction to see Joseph Oliveto's performance on stock
You May Also Like
Joseph Oliveto insider profile FAQ
What is the percentage of profitable transactions made by Joseph Oliveto?
The percentage of profitable transactions made by Joseph Oliveto is ―.
What is the average return per transaction made by Joseph Oliveto?
The average return per transaction made by Joseph Oliveto is ―.
What stocks does Joseph Oliveto hold?
Joseph Oliveto holds: CHTP, MIST stocks.
What was Joseph Oliveto’s latest transaction?
Joseph Oliveto latest transaction was an Uninformative Buy of $414.93K.
What was Joseph Oliveto's most profitable transaction?
Joseph Oliveto’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Joseph Oliveto's role in Chelsea Therapeutics?
Joseph Oliveto's role in Chelsea Therapeutics is President and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.